Spero Therapeutics, Inc. (SPRO)
1.20
+0.06
(+5.26%)
USD |
NASDAQ |
Oct 09, 16:00
1.20
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Cash and Short Term Investments (Quarterly) : 50.77M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.77M |
| March 31, 2026 | 56.13M |
| December 31, 2025 | 40.26M |
| September 30, 2025 | 48.62M |
| June 30, 2025 | 31.19M |
| March 31, 2025 | 48.89M |
| December 31, 2024 | 52.89M |
| September 30, 2024 | 76.29M |
| June 30, 2024 | 63.53M |
| March 31, 2024 | 82.27M |
| December 31, 2023 | 76.33M |
| September 30, 2023 | 93.82M |
| June 30, 2023 | 77.69M |
| March 31, 2023 | 96.25M |
| December 31, 2022 | 109.11M |
| September 30, 2022 | 50.45M |
| June 30, 2022 | 45.40M |
| March 31, 2022 | 121.97M |
| Date | Value |
|---|---|
| December 31, 2021 | 146.40M |
| September 30, 2021 | 123.42M |
| June 30, 2021 | 99.22M |
| March 31, 2021 | 115.68M |
| December 31, 2020 | 126.91M |
| September 30, 2020 | 127.24M |
| June 30, 2020 | 71.36M |
| March 31, 2020 | 88.84M |
| December 31, 2019 | 82.04M |
| September 30, 2019 | 93.86M |
| June 30, 2019 | 103.41M |
| March 31, 2019 | 106.39M |
| December 31, 2018 | 115.44M |
| September 30, 2018 | 131.22M |
| June 30, 2018 | 66.64M |
| March 31, 2018 | 75.39M |
| December 31, 2017 | 87.29M |
| September 30, 2017 | 25.37M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 36.67M |
| Fortress Biotech, Inc. | 196.58M |
| Kura Oncology, Inc. | 519.02M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |